Works matching IS 09255710 AND DT 2010 AND VI 92 AND IP 5


Results: 18
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10

    Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma: Japan Clinical Oncology Group study (JCOG 9305).

    Published in:
    2010
    By:
    • Ogura, Michinori;
    • Itoh, Kuniaki;
    • Kinoshita, Tomohiro;
    • Fukuda, Haruhiko;
    • Takenaka, Takeaki;
    • Ohtsu, Tomoko;
    • Kagami, Yoshitoyo;
    • Tobinai, Kensei;
    • Okamoto, Masataka;
    • Asaoku, Hideki;
    • Sasaki, Tsuneo;
    • Mikuni, Chikara;
    • Hirano, Masami;
    • Chou, Takaaki;
    • Ohnishi, Kazunori;
    • Ohno, Hitoshi;
    • Nasu, Kaori;
    • Okabe, Kenichi;
    • Ikeda, Shuichi;
    • Nakamura, Shigeo
    Publication type:
    journal article
    11
    12
    13
    14
    15
    16
    17

    Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with features intermediate between diffuse large B cell lymphoma and BL.

    Published in:
    2010
    By:
    • Maruyama, Dai;
    • Watanabe, Takashi;
    • Maeshima, Akiko;
    • Nomoto, Junko;
    • Taniguchi, Hirokazu;
    • Azuma, Teruhisa;
    • Mori, Masakazu;
    • Munakata, Wataru;
    • Kim, Sung-Won;
    • Kobayashi, Yukio;
    • Matsuno, Yoshihiro;
    • Tobinai, Kensei;
    • Maeshima, Akiko Miyagi
    Publication type:
    journal article
    18